Cargando…
Highly Specific Sigma Receptor Ligands Exhibit Anti-Viral Properties in SARS-CoV-2 Infected Cells
(1) Background: There is a strong need for prevention and treatment strategies for COVID-19 that are not impacted by SARS-CoV-2 mutations emerging in variants of concern. After virus infection, host ER resident sigma receptors form direct interactions with non-structural SARS-CoV-2 proteins present...
Autores principales: | Ostrov, David A., Bluhm, Andrew P., Li, Danmeng, Khan, Juveriya Qamar, Rohamare, Megha, Rajamanickam, Karthic, K. Bhanumathy, Kalpana, Lew, Jocelyne, Falzarano, Darryl, Vizeacoumar, Franco J., Wilson, Joyce A., Mottinelli, Marco, Kanumuri, Siva Rama Raju, Sharma, Abhisheak, McCurdy, Christopher R., Norris, Michael H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8620039/ https://www.ncbi.nlm.nih.gov/pubmed/34832669 http://dx.doi.org/10.3390/pathogens10111514 |
Ejemplares similares
-
Generation of a SARS-CoV-2 Reverse Genetics System and Novel Human Lung Cell Lines That Exhibit High Virus-Induced Cytopathology
por: Khan, Juveriya Qamar, et al.
Publicado: (2023) -
Sigma Receptor Ligands Prevent COVID Mortality In Vivo: Implications for Future Therapeutics
por: Berkowitz, Reed L., et al.
Publicado: (2023) -
The RNA Interference Effector Protein Argonaute 2 Functions as a Restriction Factor Against SARS-CoV-2
por: Lopez-Orozco, Joaquin, et al.
Publicado: (2023) -
Characterization of Sigma 1 Receptor Antagonist CM-304 and Its Analog, AZ-66: Novel Therapeutics Against Allodynia and Induced Pain
por: Cirino, Thomas J., et al.
Publicado: (2019) -
Protein Tyrosine Kinases: Their Roles and Their Targeting in Leukemia
por: K. Bhanumathy, Kalpana, et al.
Publicado: (2021)